Rabeprazole for the prevention of pathologic and symptomatic relapse of erosive or ulcerative gastroesophageal reflux disease. Rebeprazole Study Group (Q73234052)
Jump to navigation
Jump to search
scientific article published on 01 November 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rabeprazole for the prevention of pathologic and symptomatic relapse of erosive or ulcerative gastroesophageal reflux disease. Rebeprazole Study Group |
scientific article published on 01 November 2000 |
Statements
Rabeprazole for the prevention of pathologic and symptomatic relapse of erosive or ulcerative gastroesophageal reflux disease. Rebeprazole Study Group (English)
A Caos
M Moskovitz
Y Dayal
C Perdomo
R Niecestro
1 November 2000
1 reference
1 reference
1 reference